A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks-Reference-Cited by-同舟云学术

A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks

Published:2014-03-28 Issue:8 Volume:171 Page:2230-2242
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Villaseñor A¹,Ramamoorthy A²,Silva dos Santos M¹³,Lorenzo M P¹,Laje G⁴⁵⁶,Zarate C⁴,Barbas C¹,Wainer I W²

Affiliation:

1. Center for Metabolomics and Bioanalysis (CEMBIO); Facultad de Farmacia; Universidad CEU San Pablo; Madrid Spain

2. Laboratory of Clinical Investigation; Intramural Research Program; National Institute on Aging; National Institutes of Health (NIH); Baltimore MD USA

3. Faculty of Pharmacy; Federal University of Minas Gerais; Belo Horizonte Brazil

4. Experimental Therapeutics & Pathophysiology Branch Intramural Research Program; National Institute of Mental Health (NIMH), NIH; Bethesda MD USA

5. Human Genetics Branch and Genetic Basis of Mood and Anxiety Disorders Section; Intramural Research Program; NIMH; NIH; Bethesda MD USA

6. Maryland Institute for Neuroscience and Development (MIND); Bethesda MD USA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12494/fullpdf

Reference35 articles.

1. Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics;Abo;Pharmacogenet Genomics,2012

2. Depression and anxiety: role of mitochondria;Burroughs;Curr Anaesth Crit Care,2007

3. Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint;Ciborowski;PLoS ONE,2012

4. Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression;Di Cesare Mannelli;Psychopharmacology (Berl),2011

5. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression;Diazgranados;Arch Gen Psychiatry,2010

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine;Neuroscience Letters;2024-05

2. Metabolomic biomarkers for (R, S)‐ketamine and (S)‐ketamine in treatment‐resistant depression and healthy controls: A systematic review;Bipolar Disorders;2024-02-07

3. A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

4. Neurobiology of Mood Disorders;Tasman’s Psychiatry;2024

5. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication;Pharmaceuticals;2023-11-07